Clinical trials show encouraging results for a second investigational Alzheimer’s drug — and Brown University, Butler Hospital and Rhode Island Hospital were again deeply involved.
Nicola Neretti to join a new five-year, $10 million research effort funded by the National Institutes of Health to investigate how changes in cell structure can affect health and disease.
Brown University computational neuroscientist Stephanie Jones has received the BIOMAG2020 Mid-Career Award for her transformative contributions to the field of biomagnetism research.
By 2040, approximately one in five people in the U.S. will be 65 years old or older. As Americans are increasingly dealing with age-related diseases such as diabetes, heart disease, stroke, and Alzheimer’s, Brown researchers are trying to understand why aging occurs in an attempt to meet the country’s growing health care needs.
Deadly diseases don’t wait. Neither should good ideas. So when two undergraduates thought they’d found a way to stop neurodegeneration, they took action.
Through collaborations with neurologists, psychiatrists, biologists and more, projects spearheaded by Brown researchers aim to improve care for those with Alzheimer’s disease and their caregivers.
A major grant from the Alzheimer’s Association will enable researchers to test a drug that could reduce brain inflammation in Alzheimer’s patients and possibly slow the progression of the disease.